Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes

Overview of attention for article published in Haematologica, April 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 30 X users

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 33 X posts from 30 X users, with an upper bound of 85,529 followers.

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes | Haematologica , en nuestro Pais la causa reducción dosis costo. htt…

Haematologica: Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory cHL after ASCT: an analysis of real-world outcomes https://t.co/8Q8ZP9aGwq これって、つまり、個々の患者さんにとっての上限量を見極めて使うのが大事ってことな…

RT @DrRaulCordoba: #Hematology Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical #Hodgkin #lymp…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 29 additional X posts.